Published in Lancet on March 26, 1977
Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol Rev (1977) 13.47
Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev (1991) 7.11
Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest (1980) 6.61
Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells. Infect Immun (1978) 6.07
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev (1983) 5.73
P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun (1984) 3.50
Hemagglutination typing of Escherichia coli: definition of seven hemagglutination types. J Clin Microbiol (1980) 3.03
Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections. J Clin Microbiol (1981) 2.82
Comparative analysis of plasmids and some metabolic characteristics of Escherichia coli K1 from diseased and healthy individuals. Infect Immun (1980) 2.59
Escherichia coli in extra-intestinal infections. J Hyg (Lond) (1985) 2.51
Hemagglutination of human type O erythrocytes, hemolysin production, and serogrouping of Escherichia coli isolates from patients with acute pyelonephritis, cystitis, and asymptomatic bacteriuria. Infect Immun (1981) 1.97
Protective capacity of antibodies against Escherichia coli and K antigens. Infect Immun (1977) 1.72
Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria. Infect Immun (1978) 1.50
Genetic relationships among Escherichia coli isolates causing urinary tract infections in humans and animals. Epidemiol Infect (1989) 1.43
Urinary tract infections treated with single dose of short-acting sulphonamide. Br Med J (1979) 1.41
The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence of an extraintestinal isolate of Escherichia coli. Infect Immun (1996) 1.37
Virulence of Escherichia coli in experimental hematogenous pyelonephritis in mice. Infect Immun (1979) 1.35
Translocation of capsular polysaccharides in pathogenic strains of Escherichia coli requires a 60-kilodalton periplasmic protein. J Bacteriol (1987) 1.31
Virulence of Escherichia coli in relation to host factors in women with symptomatic urinary tract infection. J Clin Microbiol (1988) 1.28
Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity. Infect Immun (1978) 1.23
Structure and serological specificity of the K13-antigenic polysaccharide (K13 antigen) of urinary tract-infective Escherichia coli. Infect Immun (1979) 1.22
Analysis of P fimbriae on Escherichia coli O2, O4, and O6 strains by immunoprecipitation. Infect Immun (1986) 1.21
Biosynthesis of Klebsiella K2 capsular polysaccharide in Escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid (O1:K2). Infect Immun (1991) 1.21
Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1. Infect Immun (1987) 1.19
The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536. Infect Immun (2004) 1.18
Serological, chemical, and structural analyses of the Escherichia coli cross-reactive capsular polysaccharides K13, K20, and K23. Infect Immun (1983) 1.10
Sequence and expression of the Escherichia coli K1 neuC gene product. J Bacteriol (1992) 1.09
Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules. FEMS Microbiol Rev (2014) 1.05
Escherichia coli K5 antigen in relation to various infections and in healthy individuals. J Clin Microbiol (1984) 0.97
Physicochemical surface properties of Escherichia coli strains isolated from different types of urinary tract infections. Infect Immun (1981) 0.95
DNA probes for K-antigen (capsule) typing of Escherichia coli. J Clin Microbiol (1988) 0.95
Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin. Infect Immun (1983) 0.91
N-acetyl-D-neuraminic acid synthesis in Escherichia coli K1 occurs through condensation of N-acetyl-D-mannosamine and pyruvate. Biochem J (1995) 0.91
Temperature-dependent transcriptional regulation of expression of fimbriae in an Escherichia coli strain isolated from a child with severe enteritis. Infect Immun (1987) 0.90
Structure of the Escherichia coli K2 capsular antigen, a teichoic acid-like polymer. J Bacteriol (1980) 0.90
Biology and pathology of urinary tract infections. J Clin Pathol (1981) 0.89
Opsonization of various capsular (K) E. coli by the alternative complement pathway. Immunology (1983) 0.87
N-acetyl-D-neuraminic acid lyase generates the sialic acid for colominic acid biosynthesis in Escherichia coli K1. Biochem J (1996) 0.87
Chemoattractive factors from Escherichia coli: individual strain variation. Infect Immun (1981) 0.86
Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2. Proc Natl Acad Sci U S A (2011) 0.81
The Interaction between Enterobacteriaceae and Calcium Oxalate Deposits. PLoS One (2015) 0.79
Deliberate Establishment of Asymptomatic Bacteriuria-A Novel Strategy to Prevent Recurrent UTI. Pathogens (2016) 0.77
Purification and immunochemical properties of Escherichia coli B polysaccharide cross-reacting with Salmonella typhi Vi antigen: preliminary evidence for cross-reaction of the polysaccharide with Escherichia coli K1 antigen. Infect Immun (1983) 0.75
Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13. Infection (1985) 0.75
Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med (1974) 7.89
Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet (1976) 7.15
Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet (1975) 6.25
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med (1980) 5.32
Adhesion of Escherichia coli to human uroepithelial cells in vitro. Infect Immun (1977) 5.28
Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun (1981) 5.24
A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol Metab (1971) 4.38
A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned. Lancet (1996) 4.30
Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis (1984) 4.10
The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med (2001) 4.08
Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res (1973) 3.89
Genetic diversity and relationships among strains of Escherichia coli in the intestine and those causing urinary tract infections. Prog Allergy (1983) 3.12
Immunology of Escherichia coli: K antigen and its relation to urinary-tract infection. J Infect Dis (1973) 3.02
Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis (1992) 2.98
Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus. J Clin Microbiol (1985) 2.97
Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J Clin Invest (1991) 2.97
Lipid on capsular polysaccharides of gram-negative bacteria. J Biol Chem (1981) 2.91
Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide. J Exp Med (1979) 2.89
Association between urinary symptoms at 7 years old and previous urinary tract infection. Arch Dis Child (1991) 2.88
Bacterial antigens cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b. Lancet (1971) 2.84
Antibody-forming cells in human colostrum after oral immunisation. Nature (1975) 2.76
Use of antiserum agar for detection of Haemophilus influenzae type b in the pharynx. Pediatr Res (1975) 2.74
Comparison of Escherichia coli from bacteriuric patients with those from feces of healthy schoolchildren. J Infect Dis (1977) 2.72
Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis (1978) 2.72
Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet (1974) 2.67
Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future. Immunochemistry (1978) 2.65
Adhesion to normal human uroepithelial cells of Escherichia coli from children with various forms of urinary tract infection. J Pediatr (1978) 2.60
Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet (1987) 2.59
Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet (1989) 2.54
The isolation and biologic activities of purified secretory IgA and IgG anti-Salmonella typhimurium "O" antibodies from rabbit intestinal fluid and colostrum. J Immunol (1971) 2.54
Campylobacter fetus subspecies jejuni: a common cause of diarrhea in Sweden. J Infect Dis (1980) 2.53
Breast milk and defence against infection in the newborn. Arch Dis Child (1972) 2.51
Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3. Infect Immun (1972) 2.47
Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination. J Clin Microbiol (1978) 2.44
Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1. Infect Immun (1977) 2.39
The bactericidal effect of normal human serum on E. coli strains from normals and from patients with urinary tract infections. Infection (1973) 2.39
Outcome at 10 years of severe vesicoureteric reflux managed medically: Report of the International Reflux Study in Children. J Pediatr (2001) 2.36
Purification of antibodies with immunoadsorbents prepared using bromoacetyl cellulose. Immunochemistry (1967) 2.35
Adhesion of Streptococcus pneumoniae to human pharyngeal epithelial cells in vitro: differences in adhesive capacity among strains isolated from subjects with otitis media, septicemia, or meningitis or from healthy carriers. Infect Immun (1981) 2.33
Level diagnosis of symptomatic urinary tract infections in childhood. Acta Paediatr Scand (1975) 2.32
The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am J Trop Med Hyg (2000) 2.29
Differential complement resistance mediates virulence of Haemophilus influenzae type b. Infect Immun (1982) 2.23
Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect Immun (1991) 2.22
Production of monovalent antisera by induction of immunological tolerance for capsular typing of Streptococcus pneumoniae. FEMS Microbiol Lett (1992) 2.19
IgG subclasses in selective IgA deficiency: importance of IgG2-IgA deficiency. N Engl J Med (1981) 2.18
Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J Infect Dis (1984) 2.17
Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5. N Engl J Med (1975) 2.16
Gamma-A-immunoglobulin from rabbit colostrum. J Immunol (1966) 2.16
Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp (1981) 2.15
Clinical, bacteriological, and immunological characterisation of ampicillin-resistant Haemophilus influenzae type B. Lancet (1974) 2.14
A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci U S A (1998) 2.13
Standardization and control of meningococcal vaccines, group A and group C polysaccharides. J Biol Stand (1977) 2.11
Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect Immun (1991) 2.11
Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates. Infect Immun (1983) 2.10
Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis (2000) 2.04
Isolation of Campylobacter jejuni from domestic animals and pets: probable origin of human infection. J Infect (1981) 2.02
The occurrence of Campylobacter jejuni in fresh food and survival under different conditions. J Hyg (Lond) (1981) 1.98
Serological diagnosis of pneumococcal disease with enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis (1978) 1.98
Renal damage one year after first urinary tract infection: role of dimercaptosuccinic acid scintigraphy. J Pediatr (1996) 1.96
A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli. Pediatr Res (1976) 1.96
Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet (1997) 1.94
Five-year study of medical or surgical treatment in children with severe reflux: radiological renal findings. The International Reflux Study in Children. Pediatr Nephrol (1992) 1.89
Characteristics of antibiotic-resistant Escherichia coli in the rectum of healthy school-children. J Med Microbiol (1977) 1.87
Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun (1991) 1.86
Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J Infect Dis (1977) 1.84
Boosting of secretory IgA antibody responses in man by parenteral cholera vaccination. Scand J Immunol (1977) 1.83
Resistant urinary infections resulting from changes in resistance pattern of faecal flora induced by sulphonamide and hospital environment. Br Med J (1970) 1.81
Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect Immun (1986) 1.79
Primary and acquired renal scarring in boys and girls with urinary tract infection. J Pediatr (2000) 1.79
A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med (1995) 1.78
Primary hypogammaglobulinaemia: impaired lung function and body growth with delayed diagnosis and inadequate treatment. Eur J Respir Dis (1984) 1.77
Asymptomatic bacteriuria in schoolgirls. II. Differences in escherichia coli causing asymptomatic bacteriuria. Acta Paediatr Scand (1975) 1.76
Use of antiserum agar plates for serogrouping of meningococci. J Clin Pathol (1977) 1.74
Voiding cystourethrography as a predictor of reflux nephropathy in children with urinary-tract infection. AJR Am J Roentgenol (1989) 1.74
Protective factors in milk and the development of the immune system. Pediatrics (1985) 1.73
Protective capacity of antibodies against Escherichia coli and K antigens. Infect Immun (1977) 1.72
Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis. N Engl J Med (1983) 1.70
Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A. Infect Immun (1993) 1.70
Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. Infect Immun (1990) 1.69
Experimental hematogenous pyelonephritis due to Escherichia coli in rabbits: the antibody response and its protective capacity. J Infect Dis (1973) 1.66
Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides. Infect Immun (1979) 1.61